Literature DB >> 22643268

Epitrochlear sentinel lymph nodes in melanoma: interval or independent?

Travis B Kidner1, Jeong L Yoon, Mark B Faries, Donald L Morton.   

Abstract

Most primary melanomas on the distal upper extremity metastasize to a sentinel lymph node (SLN) in the axillary basin, but occasionally a primary melanoma will drain to the epitrochlear basin. The relationship between tumor-draining axillary and epitrochlear SLNs is unclear. We hypothesize that the epitrochlear SLN functions in an interval manner with the axillary lymph node basin. We queried our melanoma database to identify patients who underwent SLN biopsy for a distal upper-extremity melanoma. Patient demographics, tumor characteristics, patterns of nodal drainage, and incidence of SLN metastasis were analyzed. Of 255 patients identified, 38 (14.9%) had an epitrochlear SLN. Mean Breslow thickness was 2.26 mm. All patients with epitrochlear drainage had concurrent axillary drainage and underwent axillary and epitrochlear SLN biopsies. Of these 38 patients, two (5.2%) had epitrochlear and axillary SLN metastasis, four (10.5%) had epitrochlear metastasis only, four (10.5%) had axillary metastasis only, and the remaining 28 (73.7%) had tumor-free SLNs. The invariable association of epitrochlear and axillary drainage in this study suggests that epitrochlear nodes function in an interval role with the axillary lymph node basin. Therefore we recommend that all patients with a positive epitrochlear SLN undergo completion axillary dissection.

Entities:  

Mesh:

Year:  2012        PMID: 22643268      PMCID: PMC3367319     

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  16 in total

Review 1.  Patterns of lymphatic drainage from the skin in patients with melanoma.

Authors:  Roger F Uren; Robert Howman-Giles; John F Thompson
Journal:  J Nucl Med       Date:  2003-04       Impact factor: 10.057

2.  Micrometastasis to in-transit lymph nodes from extremity and truncal malignant melanoma.

Authors:  M C Thelmo; E T Morita; P A Treseler; L H Nguyen; R E Allen; R W Sagebiel; M Kashani-Sabet; S P Leong
Journal:  Ann Surg Oncol       Date:  2001-06       Impact factor: 5.344

3.  Interval sentinel lymph nodes in melanoma.

Authors:  Kelly M McMasters; Celia Chao; Sandra L Wong; William R Wrightson; Merrick I Ross; Douglas S Reintgen; R Dirk Noyes; Patricia B Cerrito; Michael J Edwards
Journal:  Arch Surg       Date:  2002-05

Review 4.  An aberrant lymph node containing metastatic melanoma detected by sentinel node biopsy.

Authors:  D M Moloney; S Overstall; R Allan; B W Powell
Journal:  Br J Plast Surg       Date:  2001-10

5.  Unpredictability of lymphatic drainage patterns in melanoma patients.

Authors:  Markwin G Statius Muller; Feitse A Hennipman; Paul A M van Leeuwen; Rik Pijpers; Ronald J Vuylsteke; Sybren Meijer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-02       Impact factor: 9.236

6.  Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma.

Authors:  William E Sumner; Merrick I Ross; Paul F Mansfield; Jeffrey E Lee; Victor G Prieto; Christopher W Schacherer; Jeffrey E Gershenwald
Journal:  Cancer       Date:  2002-07-15       Impact factor: 6.860

7.  Lymphatic drainage to the popliteal basin in distal lower extremity malignant melanoma.

Authors:  Tehillah S Menes; Jacob Schachter; Adam P Steinmetz; Ruth Hardoff; Haim Gutman
Journal:  Arch Surg       Date:  2004-09

8.  Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary?

Authors:  Sergi Vidal-Sicart; Francesca Pons; Silvia Fuertes; Antonio Vilalta; Ramón Rull; Susana Puig; Josep M Palou; Marisa Ortega; Teresa Castel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-03       Impact factor: 9.236

9.  Three-dimensional visualisation of lymphatic drainage patterns in patients with cutaneous melanoma.

Authors:  Hayley M Reynolds; P Rod Dunbar; Roger F Uren; Shane A Blackett; John F Thompson; Nicolas P Smith
Journal:  Lancet Oncol       Date:  2007-09       Impact factor: 41.316

10.  Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases.

Authors:  Donald L Morton; Dave S B Hoon; Alistair J Cochran; Roderick R Turner; Richard Essner; Hiroya Takeuchi; Leslie A Wanek; Edwin Glass; Leland J Foshag; Eddy C Hsueh; Anton J Bilchik; David Elashoff; Robert Elashoff
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

View more
  5 in total

1.  Interval sentinel lymph nodes in melanoma: a digital pathology analysis of Ki67 expression and microvascular density.

Authors:  Christian Marinaccio; Giuseppe Giudice; Eleonora Nacchiero; Fabio Robusto; Giuseppina Opinto; Gaetano Lastilla; Eugenio Maiorano; Domenico Ribatti
Journal:  Clin Exp Med       Date:  2015-08-15       Impact factor: 3.984

2.  Epitrochlear lymph node basin in melanoma: an extension of the axillary station or an independent basin?

Authors:  Luca Cozzaglio; Federica Marazzi; Vittorio Quagliuolo
Journal:  Updates Surg       Date:  2018-03-08

3.  Unusual presentation of primary cutaneous melanoma of the forearm with epitrochlear and axillary lymphadenopathy.

Authors:  Siok Yen Pow; Melissa Teo
Journal:  BMJ Case Rep       Date:  2018-06-04

4.  The Utility of Intraoperative Handheld Gamma Camera for Detection of Sentinel Lymph Nodes in Melanoma.

Authors:  Elgin Ozkan; Aydan Eroglu
Journal:  Nucl Med Mol Imaging       Date:  2015-05-13

5.  Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors.

Authors:  Antonio Manzo; Francesca Benaglio; Barbara Vitolo; Chandra Bortolotto; Francesca Zibera; Monica Todoerti; Claudia Alpini; Serena Bugatti; Roberto Caporali; Fabrizio Calliada; Carlomaurizio Montecucco
Journal:  Arthritis Res Ther       Date:  2016-10-22       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.